Effect of Vitamin D Deficiency and Vitamin D Supplementation on Glucose Metabolism

NCT00749918 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2008-10-20

No results posted yet for this study

Summary

This study was intended to evaluate the effect of vitamin D supplementation on insulin sensitivity and pancreatic islet beta-cell function. Our hypothesis was that vitamin D supplementation to normal levels in patients with impaired fasting glucose will result in improved insulin sensitivity and improved beta cell function.

Conditions

Interventions

DIETARY_SUPPLEMENT

Cholecalciferol (vitamin D3)

Oral capsules of cholecalciferol, 5000 IU/ capsule, two capsules daily for one month.

Sponsors & Collaborators

Principal Investigators

  • Cary Mariash, MD · University of Minnesota

  • Shaban Nazarian, MD · University of Minnesota

  • Sidney Jones, MD · University of Minnesota

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00749918 on ClinicalTrials.gov